Ask AI
evERA BC
evERA BC: Phase III Trial of Giredestrant + Everolimus in Advanced ER+/HER2- Breast Cancer Previously Treated With a CDK4/6 Inhibitor

Released: October 31, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: October 31, 2025